GVK Bio under European drug regulator scanner

October 01, 2014 11:27 pm | Updated November 16, 2021 07:15 pm IST - HYDERABAD:

The European Medicines Agency (EMA) has started a review in connection with the findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences.

The European body’s action follows an inspection by the French medicines agency, ANSM, which raised concerns over study data used by GVK Bio to support the marketing authorisation applications of generic medicines.

“The review will cover nationally authorised medicines whose marketing authorisation applications included clinical data from studies conducted by GVK Biosciences Pvt Ltd, Hyderabad. The review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission, under Article 31 of Directive 2001/83/EC,” a European drug regulator statement said.

When contacted GVK, a company official said that from May 19 to 23, a regulatory inspector from ANSM inspected their Hyderabad Clinical facility and the company had submitted necessary clarifications to the French authorities. Further, we were invited by the European authorities, GVK BIO met the European authorities in-person last week, presented the data and demonstrated how we have optimised our processes internally.

“We are in the resolution stage and hope to close the matter to their satisfaction at the earliest.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.